BridgeMD
Tests treatment safety and results for Obsessive-Compulsive Disorder (OCD)
Official title The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder
ClinicalTrials.gov ID: NCT07113652
What this study is testing
- What it's testing
- This study aims to evaluate the efficacy of Temporal Interference (TI) stimulation in treating patients with obsessive-compulsive disorder (OCD) and to explore its potential neural mechanisms using magnetic resonance imaging (MRI) and electroencephalography (EEG).
- Time commitment: about 4 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- 18-50 years old
- Diagnosis of OCD per DSM-5
- Y-BOCS score ≥20
- Have a documented history of at least two adequate trials of selective serotonin reuptake inhibitors (SSRIs). If currently receiving SSRI treatment...
- With at least 9 years of education
You likely can't join if
- Any DSM-5 diagnosis other than OCD (except OCPD)
- OCD symptoms too severe to complete assessments
- Received electroconvulsive therapy (ECT) within the past 6 months
- Received other forms of neuromodulation within the past 2 months（see Item 3 for ECT）
- Severe medical illness or seizure risk (e.g., cardiovascular, respiratory conditions)
- Neurological disorders or history of brain injury/surgery
See the full eligibility criteria
- 18-50 years old
- Diagnosis of OCD per DSM-5
- Y-BOCS score ≥20
- Have a documented history of at least two adequate trials of selective serotonin reuptake inhibitors (SSRIs). If currently receiving SSRI treatment, the dosage must be stable for at least 8 weeks prior to enrollment
- With at least 9 years of education
- Any DSM-5 diagnosis other than OCD (except OCPD)
- OCD symptoms too severe to complete assessments
- Received electroconvulsive therapy (ECT) within the past 6 months
- Received other forms of neuromodulation within the past 2 months（see Item 3 for ECT）
- Severe medical illness or seizure risk (e.g., cardiovascular, respiratory conditions)
- Neurological disorders or history of brain injury/surgery
- MRI-incompatible implants (e.g., pacemaker, stents, cochlear implants).
- Current suicidal risk per investigator judgment
- Pregnant or planning pregnancy during the study
- Started structured OCD psychotherapy within 3 months, with expected change during treatment
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.